Sinisa Dimkovic
Research Subjects
Sinisa Dimkovic has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Biljana Božić Nedeljković
Institute of Physiology and Biochemistry “Ivan Djaja”, Faculty of Biology, University of Belgrade, 11000 Belgrade, Serbia
1 shared publication - Biljana Putnikovic
University of Belgrade
1 shared publication - Goran Loncar
Dedinje Cardiovascular Institute, 11000 Belgrade, Serbia
1 shared publication - Natasa Markovic-Nikolic
Department of Cardiology, University Clinical Hospital Center Zvezdara, School of Medicine, University of Belgrade, Belgrade, Serbia
1 shared publication - Nenad Prodanovic
Military Medical Academy
1 shared publication - Toplica Lepic
Military Medical Academy
1 shared publication
Latest Publications
- 20 November 2009
- Published by Springer Nature in Endocrine
- Vol. 37 (1) , 148-156
Relationship between RANKL and neuroendocrine activation in elderly males with heart failure
The main cytokines regulating bone remodeling are the receptor activator of nuclear factor-κB ligand (RANKL) and its decoy receptor, osteoprotegerin (OPG). Recent data have linked RANKL and OPG to cardiovascular disease as well. NT-pro-BNP and adiponectin are well-established biomarkers of heart failure reflecting neuroendocrine activation in this multi-complex disorder. The objective of this article was to investigate whether RANKL is associated with neuroendocrine activation in 75 elderly males with mild to moderate congestive heart failure (CHF) and left ventricular ejection fraction P < 0.0001]. There was a significant relative risk of systolic CHF in elderly males associated with increased sRANKL above the calculated cut-off of 83 pg/ml [OR = 10.286 (95%CI 3.079–34.356), P < 0.0001; RR = 3.600 (95%CI = 1.482–8.747)]. In the CHF patients, the log-transformed values of sRANKL levels correlated positively with the log-transformed values of the serum NT-pro-BNP and adiponectin levels (P = 0.004, r = 0.326 and P = 0.037, r = 0. 241, respectively), while inversely correlated with the BMI and creatinine clearance (P = 0.015, r = −0.281 and P = 0.042, r = −0.236, respectively). In multivariate regression model, sRANKL was a significant determinant of NT-pro-BNP independent of age, BMI and creatinine clearance (P = 0.002, R 2 = 0.546). In conclusion, our study suggests that in elderly males with systolic heart failure sRANKL was significantly associated with parameters of neuroendocrine activation such as NT-pro-BNP and adiponectin. Further studies are needed to elucidate the potential role of sRANKL in the complex pathogenesis of heart failure.
- 20 November 2009
- Published by Springer Nature in Endocrine
- Vol. 37 (1) , 148-156
Relationship between RANKL and neuroendocrine activation in elderly males with heart failure
The main cytokines regulating bone remodeling are the receptor activator of nuclear factor-κB ligand (RANKL) and its decoy receptor, osteoprotegerin (OPG). Recent data have linked RANKL and OPG to cardiovascular disease as well. NT-pro-BNP and adiponectin are well-established biomarkers of heart failure reflecting neuroendocrine activation in this multi-complex disorder. The objective of this article was to investigate whether RANKL is associated with neuroendocrine activation in 75 elderly males with mild to moderate congestive heart failure (CHF) and left ventricular ejection fraction P < 0.0001]. There was a significant relative risk of systolic CHF in elderly males associated with increased sRANKL above the calculated cut-off of 83 pg/ml [OR = 10.286 (95%CI 3.079–34.356), P < 0.0001; RR = 3.600 (95%CI = 1.482–8.747)]. In the CHF patients, the log-transformed values of sRANKL levels correlated positively with the log-transformed values of the serum NT-pro-BNP and adiponectin levels (P = 0.004, r = 0.326 and P = 0.037, r = 0. 241, respectively), while inversely correlated with the BMI and creatinine clearance (P = 0.015, r = −0.281 and P = 0.042, r = −0.236, respectively). In multivariate regression model, sRANKL was a significant determinant of NT-pro-BNP independent of age, BMI and creatinine clearance (P = 0.002, R 2 = 0.546). In conclusion, our study suggests that in elderly males with systolic heart failure sRANKL was significantly associated with parameters of neuroendocrine activation such as NT-pro-BNP and adiponectin. Further studies are needed to elucidate the potential role of sRANKL in the complex pathogenesis of heart failure.